↓ Skip to main content

Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status

Overview of attention for article published in Acta Neuropathologica, January 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

news
1 news outlet
twitter
6 X users
patent
4 patents
wikipedia
1 Wikipedia page

Citations

dimensions_citation
266 Dimensions

Readers on

mendeley
298 Mendeley
Title
Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status
Published in
Acta Neuropathologica, January 2016
DOI 10.1007/s00401-016-1533-5
Pubmed ID
Authors

Laura Piccio, Yuetiva Deming, Jorge L. Del-Águila, Laura Ghezzi, David M. Holtzman, Anne M. Fagan, Chiara Fenoglio, Daniela Galimberti, Barbara Borroni, Carlos Cruchaga

Abstract

Low frequency coding variants in TREM2 are associated with increased Alzheimer disease (AD) risk, while loss of functions mutations in the gene lead to an autosomal recessive early-onset dementia, named Nasu-Hakola disease (NHD). TREM2 can be detected as a soluble protein in cerebrospinal fluid (CSF) and plasma, and its CSF levels are elevated in inflammatory CNS diseases. We measured soluble TREM2 (sTREM2) in the CSF of a large AD case-control dataset (n = 180) and 40 TREM2 risk variant carriers to determine whether CSF sTREM2 levels are associated with AD status or mutation status. We also performed genetic studies to identify genetic variants associated with CSF sTREM2 levels. CSF, but not plasma, sTREM2 was highly correlated with CSF total tau and phosphorylated-tau levels (r = 0.35, P < 1×10(-4); r = 0.40, P < 1×10(-4), respectively), but not with CSF Aβ42. AD cases presented higher CSF sTREM2 levels than controls (P = 0.01). Carriers of NHD-associated TREM2 variants presented significantly lower CSF sTREM2 levels, supporting the hypothesis that these mutations lead to reduced protein production/function (R136Q, D87N, Q33X or T66M; P = 1×10(-3)). In contrast, CSF sTREM2 levels were significantly higher in R47H carriers compared to non-carriers (P = 6×10(-3)), suggesting that this variant does not impact protein expression and increases AD risk through a different pathogenic mechanism than NHD variants. In GWAS analyses for CSF sTREM2 levels the most significant signal was located on the MS4A gene locus (P = 5.45 × 10(-07)) corresponding to one of the SNPs reported to be associated with AD risk in this locus. Furthermore, SNPs involved in pathways related to virus cellular entry and vesicular trafficking were overrepresented, suggesting that CSF sTREM2 levels could be an informative phenotype for AD.

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 298 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 298 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 51 17%
Student > Ph. D. Student 48 16%
Student > Master 26 9%
Student > Bachelor 25 8%
Student > Doctoral Student 9 3%
Other 42 14%
Unknown 97 33%
Readers by discipline Count As %
Neuroscience 69 23%
Medicine and Dentistry 34 11%
Agricultural and Biological Sciences 27 9%
Biochemistry, Genetics and Molecular Biology 23 8%
Pharmacology, Toxicology and Pharmaceutical Science 11 4%
Other 34 11%
Unknown 100 34%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 22. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 August 2023.
All research outputs
#1,492,845
of 23,543,207 outputs
Outputs from Acta Neuropathologica
#277
of 2,409 outputs
Outputs of similar age
#27,596
of 398,264 outputs
Outputs of similar age from Acta Neuropathologica
#6
of 39 outputs
Altmetric has tracked 23,543,207 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,409 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.0. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 398,264 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 39 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.